Srsf1-deficient CD8+ T cells markedly inhibited the growth of Hep1-6-OVA HCC tumors (Supplementary Fig. 2f) and enhanced mouse survival (Supplementary Fig. 2f). This evidence concerns the gene CD8A and hepatocellular carcinoma.